Wipro GE plans Rs 8,000 crore investment in indian manufacturing, R&D

  • Industry News
  • Mar 28,24
The strategic investment bolsters the company's local manufacturing footprint to address the growing domestic and international market
Wipro GE plans Rs 8,000 crore investment in indian manufacturing, R&D

Wipro GE Healthcare on 26th March, 2024, said it will invest over Rs 8,000 crore in India over the next five years to increase local manufacturing and research and development (R&D).

The company, a leading global medical technology, pharmaceutical diagnostics, and digital solutions provider, said as a part of the investment, its 'Made in India' PET CT Discovery IQ scanner will be exported to 15 countries.

Additionally, locally produced Revolution Aspire CT, Revolution ACT and MR breast coils will be manufactured 'In India for the World', the company said in a statement.

The strategic investment bolsters the company's local manufacturing footprint to address the growing domestic and international market. It will also build supply chain resiliency for the organisation, it added.

Wipro GE Healthcare, Chairman, Azim Premji said “India is riding the resurgent growth in the healthcare industry and rapidly expanding MedTech sector.”

"With 'Make in India', we are witnessing an exponential expansion of manufacturing footprint in the country, strengthening India's capability as the MedTech hub of the world.

"Wipro GE Healthcare has been committed to this localisation journey for over three decades and this strategic investment is testament to our vision for this sector," added Premji, who is also the Chairman of Wipro Enterprises and the Azim Premji Foundation.

GE HealthCare, President and CEO, Peter J Arduini said “India is a high potential, high priority market for GE HealthCare globally. In fact, we are among the first MedTech companies to 'Make in India - for India and the World'. We will continue to invest in expanding India's domestic capabilities and its global footprint in MedTech manufacturing and R&D," he said.

Further, Arduini said, "Today's announcement is aligned with our strategic vision to deliver precision innovation globally and accelerate India's position as 'MedTech innovation and manufacturing hub for India and for world markets." Wipro GE Healthcare Managing Director and President & CEO, GE HealthCare, South Asia, Chaitanya Sarawate said, "As a local partner we are bullish about India's potential and its journey to be 'Atmanirbhar' and a key cog in the resilient global supply chain.

"As India envisions to be among top five global manufacturing hubs in terms of value and technology for medical devices in the coming years, we are committed to the national healthcare agenda." At present, Wipro GE Healthcare has four manufacturing plants in Bengaluru.

All these plants are export plants and the latest one was established in March 2022, with an investment of a little over Rs 100 crore, under the Indian government's production-linked investment (PLI) Scheme, the company said.

Wipro GE Healthcare is a joint venture between GE Precision Healthcare LLC, USA, and Wipro Enterprises Ltd established in 1990. Its operations spread across India, Bangladesh, Sri Lanka, Nepal, Maldives, and Bhutan.

Related Stories

Railways
On a fast-track growth

On a fast-track growth

On September 25, 2024, Make in India initiative completed 10 years. Lauding the country’s achievements in manufacturing, Prime Minister Narendra Modi, in a LinkedIn post, described the initiative ..

Read more
Policy Regulation
GOI identifies 300 laws for potential decriminalisation to boost business

GOI identifies 300 laws for potential decriminalisation to boost business

The minister noted that the Production-Linked Incentive (PLI) schemes launched in 2020, with an outlay of Rs 1.97 trillion, have been a significant driver for 14 sectors, particularly electronics an..

Read more
Policy Regulation
Bright future for manufacturing as ‘Make in India’ marks 10 years: Piyush Goyal

Bright future for manufacturing as ‘Make in India’ marks 10 years: Piyush Goyal

Other sectors like steel, cement, and textiles have seen massive investments, contributing to the overall growth of India’s manufacturing capacity.

Read more

Related Products

Programmable Controllers - Pcd-33a Series

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Pro-Med Instruments (P) Ltd offers a wide range of programmable controllers - PCD-33A Series.


Read more

Request a Quote

Gasket Graphite Powder

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Arihant Packing & Gasket Company offers a wide range of gasket graphite powder. 


Read more

Request a Quote

Asahi Kasei expands 3D printing filament sales in North America

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Asahi Kasei, a leading resin and compounding technology provider, has initiated the sales of 3D printing (3DP) filaments in North America through Asahi Kasei Plastics North America (APNA). The soft la Read more

Request a Quote

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016

Reach out to us

Call us at +91 8108603000 or

Schedule a Call Back